WIP1 is a novel specific target for growth hormone action

Publication date

2023-11-17

Authors

Apaydin, Tugce
Zonis, Svetlana
Zhou, Cuiqi
Valencia, Christian Wong
Barrett, Robert
Strous, Ger JISNI 0000000392882081
Mol, Jan A.
Chesnokova, Vera
Melmed, Shlomo

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by_nc_nd

Abstract

DNA damage repair (DDR) is mediated by phosphorylating effectors ATM kinase, CHK2, p53, and γH2AX. We showed earlier that GH suppresses DDR by suppressing pATM, resulting in DNA damage accumulation. Here, we show GH acting through GH receptor (GHR) inducing wild-type p53-inducible phosphatase 1 (WIP1), which dephosphorylated ATM and its effectors in normal human colon cells and three-dimensional human intestinal organoids. Mice bearing GH-secreting xenografts exhibited induced colon WIP1 with suppressed pATM and γH2AX. WIP1 was also induced in buffy coats derived from patients with elevated GH from somatotroph adenomas. In contrast, decreased colon WIP1 was observed in GHR−/− mice. WIP1 inhibition restored ATM phosphorylation and reversed GH-induced DNA damage. We elucidated a novel GH signaling pathway activating Src/AMPK to trigger HIPK2 nuclear-cytoplasmic relocation and suppressing WIP1 ubiquitination. Concordantly, blocking either AMPK or Src abolished GH-induced WIP1. We identify WIP1 as a specific target for GH-mediated epithelial DNA damage accumulation.

Keywords

biochemistry, molecular biology, physiology, General

Citation

Apaydin, T, Zonis, S, Zhou, C, Valencia, C W, Barrett, R, Strous, G J, Mol, J A, Chesnokova, V & Melmed, S 2023, 'WIP1 is a novel specific target for growth hormone action', iScience, vol. 26, no. 11, 108117. https://doi.org/10.1016/j.isci.2023.108117